XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.23.3

Revenue Recognition Segment revenue by major payor (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2023
Revenues by major payor [Abstract] |
Disaggregation of Revenue [Table Text Block] | The following tables summarize the Company's segment revenues by primary payor source:
| Three months ended September 30, 2023 |  | Three months ended September 30, 2022
| U.S. dialysis |  | Other — Ancillary services |  | Consolidated |  | U.S. dialysis |  | Other — Ancillary services |  | Consolidated
Dialysis patient service revenues: |  |  |  |  |  |  |  |  |  |  |
Medicare and Medicare Advantage | $ | 1,515,860 |  |  |  |  | $ | 1,515,860 |  |  | $ | 1,535,680 |  |  |  |  | $ | 1,535,680 |
Medicaid and Managed Medicaid | 207,327 |  |  |  |  | 207,327 |  |  | 193,853 |  |  |  |  | 193,853 |
Other government | 90,549 |  |  | $ | 128,980 |  |  | 219,529 |  |  | 86,852 |  |  | $ | 116,084 |  |  | 202,936 |
Commercial | 965,331 |  |  | 68,192 |  |  | 1,033,523 |  |  | 880,812 |  |  | 56,170 |  |  | 936,982 |
Other revenues: |  |  |  |  |  |  |  |  |  |  |
Medicare and Medicare Advantage |  |  | 137,149 |  |  | 137,149 |  |  |  |  | 78,345 |  |  | 78,345 |
Medicaid and Managed Medicaid |  |  | 331 |  |  | 331 |  |  |  |  | 412 |  |  | 412 |
Commercial |  |  | 16,063 |  |  | 16,063 |  |  |  |  | 6,484 |  |  | 6,484 |
Other(1) | 6,239 |  |  | 11,832 |  |  | 18,071 |  |  | 6,056 |  |  | 10,903 |  |  | 16,959 |
Eliminations of intersegment revenues | (24,289) |  |  | (2,232) |  |  | (26,521) |  |  | (22,957) |  |  | — |  |  | (22,957) |
Total | $ | 2,761,017 |  |  | $ | 360,315 |  |  | $ | 3,121,332 |  |  | $ | 2,680,296 |  |  | $ | 268,398 |  |  | $ | 2,948,694 |
(1) Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. integrated kidney care (IKC) and other ancillary services and international operations.
| Nine months ended September 30, 2023 |  | Nine months ended September 30, 2022
| U.S. dialysis |  | Other — Ancillary services |  | Consolidated |  | U.S. dialysis |  | Other — Ancillary services |  | Consolidated
Dialysis patient service revenues: |  |  |  |  |  |  |  |  |  |  |
Medicare and Medicare Advantage | $ | 4,538,264 |  |  |  |  | $ | 4,538,264 |  |  | $ | 4,529,300 |  |  |  |  | $ | 4,529,300 |
Medicaid and Managed Medicaid | 629,118 |  |  |  |  | 629,118 |  |  | 570,380 |  |  |  |  | 570,380 |
Other government | 265,119 |  |  | $ | 376,530 |  |  | 641,649 |  |  | 253,731 |  |  | $ | 349,633 |  |  | 603,364 |
Commercial | 2,676,758 |  |  | 183,578 |  |  | 2,860,336 |  |  | 2,570,054 |  |  | 164,302 |  |  | 2,734,356 |
Other revenues: |  |  |  |  |  |  |  |  |  |  |
Medicare and Medicare Advantage |  |  | 317,624 |  |  | 317,624 |  |  |  |  | 255,204 |  |  | 255,204 |
Medicaid and Managed Medicaid |  |  | 1,296 |  |  | 1,296 |  |  |  |  | 1,181 |  |  | 1,181 |
Commercial |  |  | 20,888 |  |  | 20,888 |  |  |  |  | 16,029 |  |  | 16,029 |
Other(1) | 18,822 |  |  | 38,108 |  |  | 56,930 |  |  | 18,124 |  |  | 29,584 |  |  | 47,708 |
Eliminations of intersegment revenues | (66,698) |  |  | (5,007) |  |  | (71,705) |  |  | (64,516) |  |  | — |  |  | (64,516) |
Total | $ | 8,061,383 |  |  | $ | 933,017 |  |  | $ | 8,994,400 |  |  | $ | 7,877,073 |  |  | $ | 815,933 |  |  | $ | 8,693,006 |
(1) Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. integrated kidney care (IKC) and other ancillary services and international operations.

X
- Definition Revenues by major payor [Abstract] + References No definition available. + Details
Name: | dva_RevenuesbymajorpayorAbstract
Namespace Prefix: | dva_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration